378 - De-escalating Vancomycin in the ICU: Results of the Swab Testing to Optimize Pneumonia treatment with empiric Vancomycin (STOP-Vanc) Randomized Controlled Trial

Presenting Author(s)

• 

  Jeffrey Freiberg, MD, PhD

  Assistant Professor of Medicine
  Vanderbilt University Medical Center
  Nashville, TN, United States

  Slides

Co-Author(s)

• 

  Edward Qian, MD, MSc (he/him/his)

  Assistant Professor
  Vanderbilt University Medical Center
  Nashville, TN, United States
• KN

  Kylie Nairon, PhD

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• BE

  Ben Ereshefsky, PharmD

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• CH

  Cassandra Hennessy, MS

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• GV

  Grace Van Winkle, MPH

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• AL

  Ariel Lewis, MPH

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• JJ

  Joy Justice, n/a

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• JS

  Justin Siemann, PhD

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• JS

  Joanna Stollings, PharmD

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• TR

  Taylor Rali, n/a

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• FH

  Frank Harrell, PhD

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• CG

  Cheryl Gatto, PhD

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• GN

  George E. Nelson, MD

  Associate Professor; Director of Antimicrobial Stewardship; Associate Hospital Epidemiologist
  Vanderbilt University Medical Center
  Nashville, Tennessee, United States
• TR

  Todd Rice, MD, MSc

  Vanderbilt University Medical Center
  Nashville, Tennessee, United States